Australia Increases The Pfizer Inc (NYSE:PFE) Vaccine Order As Astra’s Roll Out Grinds To A Halt

Australia has decided to increase its Pfizer Inc (NYSE:PFE) COVID-19 vaccine by almost double. It was on Friday that Prime Minister Scott Morrison disclosed the country’s recent move. The official also spoke about the inoculation plan overhaul, revealing the rising concerns over the blood clots’ risks. Morrison disclosed that the AstraZeneca Plc vaccine wasn’t performing according to expectations, expressing fears over the clotting. 

Vaccine order

Australia has primarily relied on the AstraZeneca shot in a more significant part of its vaccination program, but that changed on Thursday. The country had ordered for about 50 million doses, which is deemed enough for its entire populace. It intended to give two shots, entrusting biopharma with the manufacturing process.

The shift in attitude in the use of the AstraZeneca vaccine is becoming clearer s time progresses. Australia happens to be one of the latest countries to showcase its reservations on using the vaccine. The restrictions come into play following the clotting fears linked to the use of this vaccine. 

The outbreak of the Covid-19 pandemic has claimed many lives worldwide, and the discovering of the earliest lot of vaccines inspired hope among most people. Research bodies and top experts dived into studies to develop vaccines to mark and end the misery. Challenging times continue, and the undesirable effects.

Government listens to local health authorities

Local health authorities in the country have been pushing for a shift, advocating for using the Pfizer product in the inoculation exercise. The authority recommends shifting to persons aged 50 and below, and the group accounts for about 12 million of the total population. 

The local authorities have compelled Australia to take the matter with urgency and seriousness, and that is why it has doubled the Pfizer Inc COVID-19 vaccine order.

The earlier order doubles to hit a figure of about 40 million shots, enough to cater to the population’s four-fifths. Morrison projects the end of this year as the most probable time for the delivery of the order. 

Australia’s policy change overhauls the initial plan to get the entire population vaccinated before October comes to a close. It anticipates that the policy change to Pfizer will work with the complexities linked to AstraZeneca.